| Dr Raymond J Murow, MD | |
|
6128 Brandon Ave Ste 201, Springfield, VA 22150-2693 | |
| (703) 780-2800 | |
| (703) 780-0461 |
| Full Name | Dr Raymond J Murow |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 53 Years |
| Location | 6128 Brandon Ave Ste 201, Springfield, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629171939 | NPI | - | NPPES |
| 4090560 | Other | VA | AETNA |
| 8132482 | Other | VA | MAMSI |
| 95014104 | Other | VA | UNITED HEALTHCARE |
| B3800001 | Other | VA | CAREFIRST BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101027461 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Home Health Llc | Fairfax, VA | Home health agency |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter.
The state's top insurance regulator criticized proposed rate hikes of as much as 20 percent for 268,000 individual policyholders, but he and other state officials don't have the authority to reject the increases.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may eventually replace the Petri dishes used today.
For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis by a researcher at the Stanford University School of Medicine suggests that only two of those lines have been used routinely.
› Verified 9 days ago
| Entity Name | Mount Vernon Internal Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679522338 PECOS PAC ID: 4587643010 Enrollment ID: O20040717000016 |
News Archive
Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter.
The state's top insurance regulator criticized proposed rate hikes of as much as 20 percent for 268,000 individual policyholders, but he and other state officials don't have the authority to reject the increases.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may eventually replace the Petri dishes used today.
For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis by a researcher at the Stanford University School of Medicine suggests that only two of those lines have been used routinely.
› Verified 9 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter.
The state's top insurance regulator criticized proposed rate hikes of as much as 20 percent for 268,000 individual policyholders, but he and other state officials don't have the authority to reject the increases.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may eventually replace the Petri dishes used today.
For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis by a researcher at the Stanford University School of Medicine suggests that only two of those lines have been used routinely.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raymond J Murow, MD 6128 Brandon Ave Ste 201, Springfield, VA 22150-2693 Ph: (703) 780-2800 | Dr Raymond J Murow, MD 6128 Brandon Ave Ste 201, Springfield, VA 22150-2693 Ph: (703) 780-2800 |
News Archive
Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical's Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter.
The state's top insurance regulator criticized proposed rate hikes of as much as 20 percent for 268,000 individual policyholders, but he and other state officials don't have the authority to reject the increases.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Using plasmas, sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. Cell culture bags of this kind are an important aid for research and clinical purposes and may eventually replace the Petri dishes used today.
For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis by a researcher at the Stanford University School of Medicine suggests that only two of those lines have been used routinely.
› Verified 9 days ago
Dr. Lynn A Daltner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5510 Alma Ln, Springfield, VA 22151 Phone: 703-642-5990 Fax: 703-642-5003 | |
Amandeep Singh, PA Internal Medicine Medicare: Medicare Enrolled Practice Location: 6128 Brandon Ave Ste 208-210, Springfield, VA 22150 Phone: 301-659-0003 Fax: 301-829-7694 | |
Anita Banerjee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5514 Alma Ln, Ste 200, Springfield, VA 22151 Phone: 703-563-1575 | |
Arehzo Jahangiri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6136 Brandon Ave, Springfield, VA 22150 Phone: 703-866-3131 | |
Dr. Walter W Immel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5510 Alma Ln, Springfield, VA 22151 Phone: 703-642-5990 Fax: 703-642-5003 | |
Dr. Allen S. Gardner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6128 Brandon Ave Ste 201, Springfield, VA 22150 Phone: 703-780-2800 Fax: 703-780-0461 | |
Dr. Margaret E Fisher, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6501 Loisdale Court, Springfield, VA 22150 Phone: 703-922-1407 Fax: 703-922-1111 |